Evidence map›Paper›PMID 28102265›Full record

ReviewNature2017

Chemical and structural effects of base modifications in messenger RNA.

Emily M Harcourt, Anna M Kietrys, Eric T Kool

Open access · greenAbstract readReview
In one paragraph

Review in Nature, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 116 papers.

0numbers the graph read from it
0cells of the map it votes in
116citing papers in PubMed
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

116 citing papers in PubMed, 204 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. RNA chemistry and therapeutics.Nature reviews. Drug discovery · 2025
    Review
  11. Localized 2'-OH Acylation at Poly(A) Extends RNA Translation.Journal of the American Chemical Society · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Exploring the methyl-verse: Dynamic interplay of epigenome and m6A epitranscriptome.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  20. Article

56 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Emily M HarcourtDepartment of Chemistry, Wellesley College, Wellesley, Massachusetts 02481, USA.
Anna M KietrysDepartment of Chemistry, Stanford University, Stanford, California 94305, USA.
Eric T KoolDepartment of Chemistry, Stanford University, Stanford, California 94305, USA.
Stanford University · USWellesley College · US

Funding

Highly Reactive Hydrazone Chemistry: Orthogonal Modification in Cellular ContextsR01GM110050 · NIGMS · STANFORD UNIVERSITY · PI KOOL, ERIC T. · 2015 to 2018
$1.2M
DNA-carbon Assemblies for Multispectral ImagingR01GM106067 · NIGMS · STANFORD UNIVERSITY · PI KOOL, ERIC T. · 2014 to 2017
$1.2M
National Institutes of Health GM106067National Institutes of Health GM110050NIGMS NIH HHS R01 GM106067NIGMS NIH HHS R01 GM110050
6 · The paper itself

Abstract

A growing number of nucleobase modifications in messenger RNA have been revealed through advances in detection and RNA sequencing. Although some of the biochemical pathways that involve modified bases have been identified, research into the world of RNA modification - the epitranscriptome - is still in an early phase. A variety of chemical tools are being used to characterize base modifications, and the structural effects of known base modifications on RNA pairing, thermodynamics and folding are being determined in relation to their putative biological roles.

Indexed as

AnimalsHumansMass SpectrometryMolecular StructureRNA, MessengerSequence Analysis, RNATranscriptomeRNA, Messenger

Identifiers

PMID28102265
PMCPMC5498787
OpenAlexW2572064190

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.